(Q48080145)

8 February 2018

title

Activation of AMPA Receptors Mediates the Antidepressant Action of Deep Brain Stimulation of the Infralimbic Prefrontal Cortex (English)

1 reference

8 February 2018

main subject

deep brain stimulation

1 reference

2

1 reference

8 February 2018

Xavier López-Gil

5

1 reference

8 February 2018

Esther Berrocoso

object named as

Esther Berrocoso

8

0 references

author name string

Laura Jiménez-Sánchez

1

1 reference

8 February 2018

Laura Pérez-Caballero

3

1 reference

8 February 2018

Marc Grifoll-Escoda

4

1 reference

8 February 2018

Leticia Campa

6

1 reference

8 February 2018

Mireia Galofré

7

1 reference

8 February 2018

Albert Adell

9

1 reference

8 February 2018

publication date

17 June 2015

1 reference

8 February 2018

published in

Cerebral Cortex

1 reference

8 February 2018

volume

26

1 reference

8 February 2018

issue

6

1 reference

8 February 2018

page(s)

2778-2789

1 reference

8 February 2018

Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCERCOR%2FBHV133

Antidepressant effects of AMPA and ketamine combination: role of hippocampal BDNF, synapsin, and mTOR

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCERCOR%2FBHV133

Antipsychotic drugs reverse the AMPA receptor-stimulated release of 5-HT in the medial prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCERCOR%2FBHV133

Differential role of AMPA receptors in mouse tests of antidepressant and anxiolytic action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCERCOR%2FBHV133

Serotonin brain circuits involved in major depression and suicide

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCERCOR%2FBHV133

NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCERCOR%2FBHV133

Antidepressant effects of ketamine in depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCERCOR%2FBHV133

The effects of chronic antidepressant treatment in an animal model of anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCERCOR%2FBHV133

Optogenetic modulation of descending prefrontocortical inputs to the dorsal raphe bidirectionally bias socioaffective choices after social defeat

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCERCOR%2FBHV133

Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCERCOR%2FBHV133

Antidepressant effect of optogenetic stimulation of the medial prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCERCOR%2FBHV133

Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCERCOR%2FBHV133

Involvement of 5-HT1A receptors in prefrontal cortex in the modulation of dopaminergic activity: role in atypical antipsychotic action

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCERCOR%2FBHV133

Cerebral metabolic correlates as potential predictors of response to anterior cingulotomy for treatment of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCERCOR%2FBHV133

The use of c-fos as a metabolic marker in neuronal pathway tracing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCERCOR%2FBHV133

Elevated level of metabotropic glutamate receptor 2/3 in the prefrontal cortex in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCERCOR%2FBHV133

Areal and synaptic interconnectivity of prelimbic (area 32), infralimbic (area 25) and insular cortices in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCERCOR%2FBHV133

Ketamine elicits sustained antidepressant-like activity via a serotonin-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCERCOR%2FBHV133

Antidepressant-like effects of medial prefrontal cortex deep brain stimulation in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCERCOR%2FBHV133

Increased levels of glutamate in brains from patients with mood disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCERCOR%2FBHV133

Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCERCOR%2FBHV133

The medial prefrontal cortex in the rat: evidence for a dorso-ventral distinction based upon functional and anatomical characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCERCOR%2FBHV133

Brainstem projections to midline and intralaminar thalamic nuclei of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCERCOR%2FBHV133

Clozapine and haloperidol differently suppress the MK-801-increased glutamatergic and serotonergic transmission in the medial prefrontal cortex of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCERCOR%2FBHV133

Probing and regulating dysfunctional circuits using deep brain stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCERCOR%2FBHV133

PI3K/AKT/mTOR signaling-mediated neuropeptide VGF in the hippocampus of mice is involved in the rapid onset antidepressant-like effects of GLYX-13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCERCOR%2FBHV133

Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCERCOR%2FBHV133

Noradrenergic antidepressants increase cortical dopamine: potential use in augmentation strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCERCOR%2FBHV133

Limbic-cortical dysregulation: a proposed model of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCERCOR%2FBHV133

Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCERCOR%2FBHV133

Deep brain stimulation for treatment-resistant depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCERCOR%2FBHV133

Cellular effects of deep brain stimulation: model-based analysis of activation and inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCERCOR%2FBHV133

High field FMRI reveals thalamocortical integration of segregated cognitive and emotional processing in mediodorsal and intralaminar thalamic nuclei

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCERCOR%2FBHV133

Mechanisms of action of deep brain stimulation(DBS) .

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCERCOR%2FBHV133

Correlation of cerebral blood flow and treatment effects of repetitive transcranial magnetic stimulation in depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCERCOR%2FBHV133

Decreased regional brain metabolism after ect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCERCOR%2FBHV133

Early responses to deep brain stimulation in depression are modulated by anti-inflammatory drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCERCOR%2FBHV133

Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCERCOR%2FBHV133

Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCERCOR%2FBHV133

Deep brain stimulation of the lateral habenula in treatment resistant major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCERCOR%2FBHV133

Behavioral and neurobiological effects of deep brain stimulation in a mouse model of high anxiety- and depression-like behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCERCOR%2FBHV133

Transient inactivation of the infralimbic cortex induces antidepressant-like effects in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCERCOR%2FBHV133

Antidepressant-like effects of cortical deep brain stimulation coincide with pro-neuroplastic adaptations of serotonin systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCERCOR%2FBHV133

Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCERCOR%2FBHV133

Magnetic Resonance Spectroscopy Studies of Glutamate-Related Abnormalities in Mood Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCERCOR%2FBHV133

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCERCOR%2FBHV133

Effects of acute and chronic administration of MK-801 on c-Fos protein expression in mice brain regions implicated in schizophrenia with or without clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCERCOR%2FBHV133

Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCERCOR%2FBHV133

21 January 2018

Identifiers

DOI

10.1093/CERCOR/BHV133

1 reference

8 February 2018

1 reference

8 February 2018